Correction Volume 10, Issue 11 pp 3626
Correction: MicroRNA-939 inhibits cell proliferation via targeting LRSAM1 in Hirschsprung’s disease
- 1 State Key Laboratory of Reproductive Medicine, Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
- 2 Key Laboratory of Modern Toxicology (Nanjing Medical University), Nanjing, China
- 3 Department of Pediatric Surgery, Children’s Hospital of Nanjing Medical University, Nanjing 210008, China
- 4 Department of Endocrinology and Metabolism, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
published: November 12, 2018 ;https://doi.org/10.18632/aging.101650
How to Cite
Copyright: Chen et al. This is an open‐access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Original article: Aging (Albany NY) 2017; 9:2471-2479.
This article has been corrected: The authors have submitted the wrong composite of Figure 1 (C), the mistake was in the 293T and SH-SY5Y cell line. The corrected panel C of Figure 1 is provided below. The authors declare that this correction does not change the results or conclusions of this paper. The authors sincerely apologize for this error.
Figure 1. Mir-939 was upregulated in HSCR tissues and cytobiology change after treating cells with its mimics. (A) Mir-939 was significantly overexpressed in HSCR (n=80) tissues compared with control samples (n=80). Human 293T, SK-N-BE(2), SH-SY5Y cell lines were transfected with miR-939 mimics, upregulated mir-939 suppressed cell proliferation indicated by the CCK-8 assay (B) without impact on cell migration (C), cell cycle (D) and cell apoptosis (E). *indicates significant difference compared with control group, P<0.05.